Active	Status	Sponsor type	Region	Phase	Filter
4 Active 2 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Deng, Guofang
TB-TRUST, NCT03867136: Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)	Completed	4	354	RoW	PZA sensitivity guided ultra-short all Oral Regimen, Standardized Shorter Regimen	Huashan Hospital	Multidrug Resistant Tuberculosis	08/24	08/24
TB-TRUSTplus, NCT04717908: Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS	Completed	N/A	89	RoW	Bedaquiline, BDQ, Pyrazinamide, PZA, Linezolid, LZD, Cycloserine, Cs, Clofazimine, CFZ	Huashan Hospital	Multidrug Resistant Tuberculosis	06/24	06/24
GRACE-TB, NCT03604848: NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB	Not yet recruiting	N/A	488	RoW	WHO-approved MDR-TB regimen, NGS-guided regimen: Regimen A, NGS-guided regimen: Regimen B, NGS-guided regimen: Regimen C	Huashan Hospital	Multidrug Resistant Tuberculosis	08/24	08/24
TCCT, NCT04484129: MDR-TB Close Contacts Tracing in China ( Study)	Not yet recruiting	N/A	500	RoW		Huashan Hospital	Multidrug Resistant Tuberculosis	12/22	12/22